BLINATUMOMAB

Spain

Medications containing this active substance

Blincyto 38.5 mcg powder for concentrate for solution for infusion

Form: powder for concentrate and solution for infusion

Active substance	Dosage
BLINATUMOMAB	38,5 µg

ATC: L01F L01FX L01FX07

Manufacturer: Amgen Europe B.V.